These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7564996)

  • 21. Impairments in multibacillary leprosy; a study from Brazil.
    Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
    Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological manifestations of Hansen's disease and their management.
    Agrawal A; Pandit L; Dalal M; Shetty JP
    Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
    Kishore BN; Shetty JN
    Indian J Lepr; 1995; 67(3):301-8. PubMed ID: 8576609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of surgical decompression of ulnar nerve in leprosy.
    Husain S; Mishra B; Prakash V; Malaviya GN
    Acta Leprol; 1998; 11(1):17-20. PubMed ID: 9693687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
    Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy.
    Sharma P; Kar HK; Beena KR; Kaur H; Narayan R
    Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampicin and isoniazid in the treatment of leprous nerve abscesses.
    Husain S; Mishra B; Malaviya GN
    Acta Leprol; 1997; 10(3):147-50. PubMed ID: 9259885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of sensibility in irreparable ulnar and median nerve lesions with use of sensory nerve transfer: long-term follow-up of 20 cases.
    Ozkan T; Ozer K; Gülgönen A
    J Hand Surg Am; 2001 Jan; 26(1):44-51. PubMed ID: 11172367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulnar and median nerves in paucibacillary leprosy--a follow-up study of electrophysiological functions in patients before and after nerve trunk decompression.
    Husain S; Kumar A; Yadav VS; Malaviya GN
    Lepr Rev; 2003 Dec; 74(4):374-82. PubMed ID: 14750583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical analysis of multibacillary leprosy patients after 1-year fixed World Health Organization recommended multidrug therapy at Yangon General Hospital, Myanmar.
    Kyaw K; Tsoh TM; Swe SY; Nagaoka Y; Takezaki S; Suzuki K; Ishii N
    J Dermatol; 2008 May; 35(5):264-9. PubMed ID: 18477225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
    Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on trend of relapse in leprosy and factors influencing relapse.
    Ali MK; Thorat DM; Subramanian M; Parthasarathy G; Selvaraj U; Prabhakar V
    Indian J Lepr; 2005; 77(2):105-15. PubMed ID: 16044808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsurgical repair of peripheral trigeminal nerve injuries from maxillofacial trauma.
    Bagheri SC; Meyer RA; Khan HA; Steed MB
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1791-9. PubMed ID: 19686912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.